Latest Price Targets from the World's Best Analysts & Research Firms
| Analyst & Firm | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
|
WF
10726
Wells Fargo
Jason Haas
|
Cintas
CTAS
$81.4B
| $202.07 | $221 |
9%
upside
| Equal-Weight |
1 Jul ‘25
2 months ago |
|
|
K
10727
Keybanc
Ken Newman
|
Emerson Electric
EMR
$74.3B
| $132.05 | $155 |
17%
upside
| Overweight |
1 Jul ‘25
2 months ago |
|
|
K
10728
Keybanc
Todd Thomas
|
Americold
COLD
$3.84B
| $13.48 | $23 |
71%
upside
| Overweight |
1 Jul ‘25
2 months ago |
|
|
WF
10729
Wells Fargo
Anthony Trainor
|
Sweetgreen
SG
$1.03B
| $8.68 | $19 |
119%
upside
| Overweight |
1 Jul ‘25
2 months ago |
|
|
MR
10730
Melius Research
Scott Davis
|
Carrier Global
CARR
$54B
| $63.47 | $90 |
42%
upside
| Hold |
1 Jul ‘25
2 months ago |
|
|
U
10731
UBS
Michael Goldsmith
|
Kite Realty
KRG
$5B
| $22.74 | $24 |
6%
upside
| Neutral |
1 Jul ‘25
2 months ago |
|
|
WR
10732
Wolfe Research
Andy Chen
|
VRNA
Verona Pharma
VRNA
$9.19B
| $106.30 | $170 |
60%
upside
| Outperform |
1 Jul ‘25
2 months ago |
|
|
U
10733
UBS
David Dai
|
Summit Therapeutics
SMMT
$14B
| $18.82 | $30 |
59%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
|
U
10734
UBS
Myles Allsop
|
Southern Copper
SCCO
$81.1B
| $99.91 | $103.96 |
4%
upside
| Neutral |
1 Jul ‘25
2 months ago |
|
|
S
10735
Scotiabank
George Farmer
|
INmune Bio
INMB
$47.3M
| $1.78 | $0.6000 |
66%
downside
| Sector Underperform |
1 Jul ‘25
2 months ago |
|
|
JM
10736
JP Morgan
Hong Zhang
|
Weyerhaeuser
WY
$18.2B
| $25.27 | $30 |
19%
upside
| Overweight |
1 Jul ‘25
2 months ago |
|
|
N
10737
Needham
Joshua Reilly
|
Crexendo
CXDO
$198M
| $6.55 | $8 |
22%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
|
K
10738
Keybanc
Alex Markgraff
|
Robinhood
HOOD
$105B
| $118.50 | $110 |
7%
downside
| Overweight |
1 Jul ‘25
2 months ago |
|
|
JM
10739
JP Morgan
Joseph Greff
|
Melco Resorts & Entertainment
MLCO
$3.77B
| $9.65 | $9.50 |
2%
downside
| Overweight |
1 Jul ‘25
2 months ago |
|
|
HW&C
10740
HC Wainwright & Co.
Mitchell Kapoor
|
Tyra Biosciences
TYRA
$630M
| $11.82 | $30 |
154%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
|
CP
10741
Compass Point
Giuliano Bologna
|
New Fortress Energy
NFE
$398M
| $1.40 | $8.50 |
507%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
|
HW&C
10742
HC Wainwright & Co.
Mitchell Kapoor
|
Summit Therapeutics
SMMT
$14B
| $18.82 | $44 |
134%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
|
HW&C
10743
HC Wainwright & Co.
Joseph Pantginis
|
PDS Biotechnology
PDSB
$55.5M
| $1.18 | $13 |
1,002%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
|
HW&C
10744
HC Wainwright & Co.
Emily Bodnar
|
NextCure
NXTC
$13.6M
| $5.07 | $36 |
610%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
|
K
10745
Keybanc
Todd Thomas
|
LINE
Lineage, Inc. Common Stock
LINE
$9.54B
| $41.71 | $84 |
101%
upside
| Sector Weight |
1 Jul ‘25
2 months ago |
|
|
N
10746
Needham
Gil Blum
|
Taysha Gene Therapies
TSHA
$895M
| $3.28 | $8 |
144%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
|
TS
10747
TD Securities
Andrew Charles
|
Sweetgreen
SG
$1.03B
| $8.68 | $15 |
73%
upside
| Hold |
1 Jul ‘25
2 months ago |
|
|
N
10748
Needham
Joseph Stringer
|
Stoke Therapeutics
STOK
$1.21B
| $22.07 | $22 |
0%
downside
| Buy |
1 Jul ‘25
2 months ago |
|
|
RC
10749
RBC Capital
Gerard Cassidy
|
Bank of America
BAC
$372B
| $50.29 | $53 |
5%
upside
| Outperform |
30 Jun ‘25
2 months ago |
|
|
LP
10750
Leerink Partners
Jonathan Chang
|
Zai Lab
ZLAB
$3.5B
| $31.49 | $75 |
138%
upside
| Outperform |
30 Jun ‘25
2 months ago |
|